Future of the "DITA for Pharmaceutical Content" subcommittee

Don Day and I are pleased to see a growing interest in DITA across
    the pharmaceutical industry. A number of pharmaceutical companies
    have implemented DITA to evaluate the standard, and the Drug
    Information Association (DIA) included a session titled
    "Implementing Structured Authoring: Understanding the DITA Model and
    Its Applicability for Content and Metadata Management" in their
    annual meeting this year (see http://tinyurl.com/cxcnpbm). 

    

    At one time it appeared that a DITA TC subcommittee would play an
    active role in supporting these efforts. However, the Pharmaceutical
    Content subcommittee has been inactive for over 18 months now. 
    

      

        
 

        
At OASIS request, we are closing
          subcommittees that either are inactive or have completed their
          work. As TC chairs, Don Day and I are considering closing the
          Pharma subcommittee, but before we do so, we wanted to shout
          out to SC members and the TC members at-large to see if there
          are any individuals interested in stepping forward and leading
          this subcommittee and its work effort.

        
 

        
Let us know if you have time and ability
          to provide leadership for this subcommittee. Otherwise, we'll
          make a motion to close the subcommittee at a future TC
          meeting. (The subcommittee always can be reactivated at a time
          when there is leadership and a group of committed members.)

        
 

        
Best,

        
  

        
Kris

        
  

        
Kristen James Eberlein

        
Principal consultant, Eberlein
          Consulting 

          Co-chair, OASIS DITA Technical Committee 

          Charter member, OASIS DITA Adoption Committee 

          www.eberleinconsulting.com

        
+1 919 682-2290; kriseberlein (skype)